Beijing Kawin Technology Share-Holding Co., Ltd. (SHA:688687)

Market Cap	4.63B
Revenue (ttm)	1.25B
Net Income (ttm)	147.36M
Shares Out	167.44M
EPS (ttm)	0.88
PE Ratio	31.42
Forward PE	27.51
Dividend	0.25 (0.90%)
Ex-Dividend Date	May 22, 2024

Volume	19,362,180
Average Volume	8,591,964
Open	28.70
Previous Close	29.00
Day's Range	27.47 - 29.84
52-Week Range	18.97 - 33.79
Beta	1.11
RSI	55.09
Earnings Date	Aug 8, 2025

About SHA:688687

Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China. The company’s products include recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon Alfacon-2 Injection; and compound glycyrrhizin tablets, capsules, and injections, as well as pirfenidone tablets. The company was founded in 2008 and is based in Beijing, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 584
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688687

Financial Performance

In 2024, SHA:688687's revenue was 1.23 billion, a decrease of -12.81% compared to the previous year's 1.41 billion. Earnings were 143.83 million, an increase of 23.44%.